Clinical Trial Update: OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 study of OTX-DP for chronic allergic conjunctivitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• OTX-DP

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Chronic Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2016-05-09